Back to Agenda
CDER Town Hall: Part 1 of 2
Session Chair(s)
Nancy D. Smith, PhD
Adjunct Professor
Temple University, FDA Alumni, United States
This forum is a roundtable discussion with CDER leadership. Topics to be discussed will depend on the interests of the audience. Panel members will discuss and update regulatory changes and the current hot topics at CDER.
Part 2 of this forum will take place Thursday, June 27 at 10:45 am
Learning Objective : Summarize key issues discussed by CDER management; Identify regulatory hot topics in drug development and regulation.
Speaker(s)
Panelist
Gerald Dal Pan, MD, MHS
FDA, United States
Director, Office of Surveillance and Epidemiology, CDER
Panelist
John Jenkins
John K. Jenkins Advisors, LLC, United States
Principal
Panelist
Justina Molzon, JD, MS
Consumer Services, United States
Consumer Services
Panelist
Robert T. O'Neill, PhD
FDA, United States
Senior Statistical Advisor, Office of Translational Sciences, CDER
Panelist
Robert J. Temple, MD
FDA, United States
Senior Advisor for Clinical Science, OCD and Immediate Office, OND, CDER
Have an account?